| TRIPELENNAMINE HYDROCHLORIDE |
盐酸曲吡那敏 |
154-69-8 |
| ER-000444793 |
792957-74-5 |
792957-74-5 |
| Ca2+ channel agonist 1 |
1402821-24-2 |
1402821-24-2 |
| DG172 (dihydrochloride) |
1361504-77-9 |
1361504-77-9 |
| N-(4,5-dihydronaphtho[1,2-d]thiazol-2-yl)-2-(3,4-dimethoxyphenyl)acetamide |
557782-81-7 |
557782-81-7 |
| IMegliMin (hydrochloride) |
(6R)-1,6-二氢-N2,N2,6-三甲基-1,3,5-三嗪-2,4-二胺盐酸盐 |
775351-61-6 |
| Psoralenoside |
补骨脂苷 |
905954-17-8 |
| ETC-1002 |
贝派地酸 |
738606-46-7 |
| P 22077 |
P 22077 |
1247819-59-5 |
| GV-58 |
(2R)-2-[[6-[[(5-甲基噻吩-2-基)甲基]氨基]-9-丙基-9H-嘌呤-2-基]氨基]丁烷-1-醇 |
1402821-41-3 |
| GlyT2-IN-1 |
CS-2063 |
448947-81-7 |
| AS1842856 |
5-氨基-7-(环己基氨基)-1-乙基-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸 |
836620-48-5 |
| GSK 2830371 |
GSK 2830371 |
1404456-53-6 |
| ROR gamma-t-IN-1 |
N-(2,6-二氯-2'-(三氟甲氧基)-[1,1'-联苯]-4-基)-2-(4-(乙基磺酰基)苯基)乙酰胺 |
1426802-50-7 |
| N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide |
N-(4-甲基-2-噻唑基)-2-[(6-苯基-3-哒嗪基)硫基]-乙酰胺 |
893990-34-6 |
| NBI-74330 |
N-[(1R)-1-[3-(4-乙氧基苯基)-3,4-二氢-4-氧代吡啶并[2,3-D]嘧啶-2-基]乙基]-4-氟-N-(3-吡啶基甲基)-3-(三氟甲基)苯乙酰胺 |
855527-92-3 |
| 2-Methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[O-(2-methylbenzoyl)oxime] |
2-甲基-5-(1-甲基乙基)-2,5-环己二烯-1,4-二酮 1-[O-(2-甲基苯甲酰)肟] |
321688-88-4 |
| Pasiniazid |
帕司烟肼 |
2066-89-9 |
| 5'-ISOBUTYLTHIO-5'-DEOXYADENOSINE |
5ˊ-异丁硫基-5ˊ-脱氧腺苷 |
35899-54-8 |
| H-MET-ALA-GLY-PRO-HIS-PRO-VAL-ILE-VAL-ILE-THR-GLY-PRO-HIS-GLU-GLU-OH |
NFAT INHIBITOR |
249537-73-3 |
